Iqirvo (elafibranor)

pCPA File Number: 23177

Negotiation Status:

Under consideration for negotiation

Indication(s):

Primary biliary cholangitis

Sponsor/Manufacturer:

Ipsen Biopharmaceuticals Canada, Inc.

CDA-AMC Project Number:

SR0865-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable